Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ltd Fund Master Healthcare Broadfin

Affiliations

  • Director at Biodelivery Sciences International Inc (BDSI), 2019-05-14
  • Director at Avadel Pharmaceuticals Plc (AVDL), 2019-02-05
  • Large Shareholder at Aratana Therapeutics Inc. (PETX), 2019-01-22
  • Large Shareholder at Novelion Therapeutics Inc. (NVLN), 2018-12-27
  • Large Shareholder at Corium International Inc. (CORI), 2018-11-28
  • Large Shareholder at Recro Pharma Inc. (REPH), 2018-05-24
  • Large Shareholder at Mirati Therapeutics Inc. (MRTX), 2017-11-20
  • Large Shareholder at Progenics Pharmaceuticals Inc (PGNX), 2017-02-15
  • Large Shareholder at Aegerion Pharmaceuticals Inc. (AEGR), 2016-12-01
  • Large Shareholder at Strata Skin Sciences Inc. (SSKN), 2016-03-14
  • Large Shareholder, Other at Cardica Inc (CRDC), 2015-09-15
  • Large Shareholder at Retrophin Inc. (RTRX), 2015-01-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
REPH $6.00 650,000 Large Shareholder 3,100,086 2016-12-13 Filing
AEGR $1.75 75,000 Large Shareholder 4,361,291 2016-09-13 Filing
AEGR $1.70 76,000 Large Shareholder 4,286,291 2016-09-12 Filing
AEGR $1.70 100,000 Large Shareholder 4,210,291 2016-09-12 Filing
AEGR $1.60 100,000 Large Shareholder 4,110,291 2016-09-09 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BDSI $5.00 1,800,000 Director 4,281,943 2019-05-10 Filing
BDSI $5.00 2,000,000 Director 4,281,943 2019-04-11 Filing
NVLN $0.85 100,000 Large Shareholder 1,498,553 2018-12-27 Filing
NVLN $0.85 56,316 Large Shareholder 1,598,553 2018-12-27 Filing
NVLN $0.88 14,800 Large Shareholder 1,654,869 2018-12-27 Filing